Rapid screening test for adulteration in raw materials of dietary supplements

Champagne, Andrea B.; Emmel, Katrina V.

doi:10.1016/j.vibspec.2010.11.009

Cited by 46 publications

(22 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This applies to some protein supplements in which it has been shown that melamine is added as a low-cost substitute for the more expensive protein ingredients (25). Committee.…”

Section: Supplement Contamination and Quality Assurance Issuesmentioning

confidence: 99%

Quality Assurance Issues in the Use of Dietary Supplements, with Special Reference to Protein Supplements

Maughan

2013

The Journal of Nutrition

View full text Add to dashboard Cite

The use of dietary supplements is widespread in the general population, in athletes and recreational exercisers, and in military personnel. A wide array of supplements is available, but protein-containing products are consistently among the most popular, especially among those who engage in resistance training. There are significant risks associated with the use of unregulated dietary supplements. Risks include the absence of active ingredients, the presence of harmful substances (including microbiological agents and foreign objects), the presence of toxic agents, and the presence of potentially dangerous prescription-only pharmaceuticals. There is ample evidence of athletes who have failed doping tests because of the use of dietary supplements. There is also growing evidence of risks to health and of serious adverse events, including a small number of fatalities, as a result of supplement use. The risk associated with the use of protein powders produced by major manufacturers is probably low, and the risk can be further reduced by using only products that have been tested under one of the recognized supplement quality assurance programs that operate in various countries. Nevertheless, a small risk remains, and athletes, soldiers, and other consumers should conduct a cost-benefit analysis before using any dietary supplements.

show abstract

“…This applies to some protein supplements in which it has been shown that melamine is added as a low-cost substitute for the more expensive protein ingredients (25). Committee.…”

Section: Supplement Contamination and Quality Assurance Issuesmentioning

confidence: 99%

Quality Assurance Issues in the Use of Dietary Supplements, with Special Reference to Protein Supplements

Maughan

2013

The Journal of Nutrition

View full text Add to dashboard Cite

show abstract

“…When screening for known analogues techniques such as IR, NIR, or RAMAN, and combinations thereof, could be useful [8,80,81]. These techniques heavily rely on a solid library of reference material (analogues + excipients) to screen against.…”

Section: Dioxo-acetildenafil Dioxo-hongdenafilmentioning

confidence: 99%

Towards a decade of detecting new analogues of sildenafil, tadalafil and vardenafil in food supplements: A history, analytical aspects and health risks

Venhuis

Kaste

2012

Journal of Pharmaceutical and Biomedical Analysis

158

116

View full text Add to dashboard Cite

“…The identification of these derivatives is done as described in sub-section 2.3, but the use of FT-IR [68,69], NIR [69,70], Raman [69,[71][72][73], NMR [74] spectroscopies and X-ray diffraction analysis [75] has also been described. …”

Section: Counterfeit Productsmentioning

confidence: 99%

Identification in drug quality control and drug research

Gǒrög

2015

TrAC Trends in Analytical Chemistry

View full text Add to dashboard Cite

Rapid screening test for adulteration in raw materials of dietary supplements

Cited by 46 publications

References 14 publications

Quality Assurance Issues in the Use of Dietary Supplements, with Special Reference to Protein Supplements

Quality Assurance Issues in the Use of Dietary Supplements, with Special Reference to Protein Supplements

Towards a decade of detecting new analogues of sildenafil, tadalafil and vardenafil in food supplements: A history, analytical aspects and health risks

Identification in drug quality control and drug research

Contact Info

Product

Resources

About